NCT00550823

Brief Summary

The diagnosis of infective endocarditis is based on the results of blood culture and findings on transeosophageal echocardiography. Cardiac computarized tomography is a new modality, mainly used for the imaging of coronary arteries. Its use in the diagnosis of infective endocarditis is not well known.The purpose of this study is to establish the use of cardiac CT in infective endocarditis.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2007

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 30, 2007

Completed
2 days until next milestone

Study Start

First participant enrolled

November 1, 2007

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
Last Updated

October 30, 2007

Status Verified

October 1, 2007

First QC Date

October 27, 2007

Last Update Submit

October 29, 2007

Conditions

Infective Endocarditis

Outcome Measures

Primary Outcomes (1)

  • The diagnostic capacity of cardiac CT in comparison with TEE in the diagnosis of infective endocarditis

    1 year

Secondary Outcomes (1)

  • Assessment of cardiac function in patients with infective endocarditis

    1 year

Study Arms (1)

A,1

EXPERIMENTAL
Device: Cardiac CT 0BRILLIANT 64

Interventions

Cardiac CT 0BRILLIANT 64DEVICE

Cardiac CT

A,1

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with infective endocarditis

You may not qualify if:

  • Allergy to contrast agent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Endocarditis

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Ori Elkayam, M.D

    Tel Aviv Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

October 27, 2007

First Posted

October 30, 2007

Study Start

November 1, 2007

Study Completion

November 1, 2008

Last Updated

October 30, 2007

Record last verified: 2007-10